Vig et al. [31] and Cui et al. [32] found that GRP78 and miR-495-3p could be regarded as the outcome measures of pancreatic cancer and gastric cancer, which showed that the two had great potential in future clinical medical evaluation. Here, HSPA5 is linked to gastric cancer.